SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-13-004383
Filing Date
2013-08-06
Accepted
2013-08-06 16:19:30
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 a8113010q.htm 10-Q 1067990
2 EXHIBIT 10.5 ex10_5.htm EX-10.5 136611
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 15253
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 15456
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6482
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 6062
  Complete submission text file 0001214659-13-004383.txt   8102178

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS anth-20130630.xml EX-101.INS 796179
8 EXHIBIT 101.SCH anth-20130630.xsd EX-101.SCH 43540
9 EXHIBIT 101.CAL anth-20130630_cal.xml EX-101.CAL 41653
10 EXHIBIT 101.DEF anth-20130630_def.xml EX-101.DEF 162200
11 EXHIBIT 101.LAB anth-20130630_lab.xml EX-101.LAB 649627
12 EXHIBIT 101.PRE anth-20130630_pre.xml EX-101.PRE 288759
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 131013769
SIC: 2834 Pharmaceutical Preparations